166 related articles for article (PubMed ID: 23826368)
1. Role of mTOR, Bad, and Survivin in RasGAP Fragment N-Mediated Cell Protection.
Peltzer N; Vanli G; Yang JY; Widmann C
PLoS One; 2013; 8(6):e68123. PubMed ID: 23826368
[TBL] [Abstract][Full Text] [Related]
2. RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.
Cailliau K; Lescuyer A; Burnol AF; Cuesta-Marbán Á; Widmann C; Browaeys-Poly E
J Biol Chem; 2015 Aug; 290(32):19653-65. PubMed ID: 26109071
[TBL] [Abstract][Full Text] [Related]
3. The activity of the anti-apoptotic fragment generated by the caspase-3/p120 RasGAP stress-sensing module displays strict Akt isoform specificity.
Vanli G; Peltzer N; Dubuis G; Widmann C
Cell Signal; 2014 Dec; 26(12):2992-7. PubMed ID: 25246356
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Buzhong Yiqi decoction on expression of Bad, NF-κB, caspase-9, Survivin, and mTOR in nude mice with A549/DDP transplantation tumors].
Liu YL; Yi JL; Liu CY
Zhongguo Zhong Yao Za Zhi; 2017 Feb; 42(4):725-730. PubMed ID: 28959844
[TBL] [Abstract][Full Text] [Related]
5. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
7. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
8. CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells.
Roca H; Varsos ZS; Pienta KJ
Neoplasia; 2009 Dec; 11(12):1309-17. PubMed ID: 20019839
[TBL] [Abstract][Full Text] [Related]
9. Regulated in DNA damage and development 1 (REDD1) promotes cell survival during serum deprivation by sustaining repression of signaling through the mechanistic target of rapamycin in complex 1 (mTORC1).
Dennis MD; McGhee NK; Jefferson LS; Kimball SR
Cell Signal; 2013 Dec; 25(12):2709-16. PubMed ID: 24018049
[TBL] [Abstract][Full Text] [Related]
10. Orexin/hypocretin activates mTOR complex 1 (mTORC1) via an Erk/Akt-independent and calcium-stimulated lysosome v-ATPase pathway.
Wang Z; Liu S; Kakizaki M; Hirose Y; Ishikawa Y; Funato H; Yanagisawa M; Yu Y; Liu Q
J Biol Chem; 2014 Nov; 289(46):31950-31959. PubMed ID: 25278019
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin prevents cadmium-induced neuronal cell death via targeting both mTORC1 and mTORC2 pathways.
Xu C; Liu C; Liu L; Zhang R; Zhang H; Chen S; Luo Y; Chen L; Huang S
Neuropharmacology; 2015 Oct; 97():35-45. PubMed ID: 26002629
[TBL] [Abstract][Full Text] [Related]
12. Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin.
Abe A; Kokuba H
Oncol Rep; 2013 Apr; 29(4):1333-42. PubMed ID: 23338618
[TBL] [Abstract][Full Text] [Related]
13. EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells.
Wang H; Gambosova K; Cooper ZA; Holloway MP; Kassai A; Izquierdo D; Cleveland K; Boney CM; Altura RA
BMC Mol Biol; 2010 Aug; 11():66. PubMed ID: 20807437
[TBL] [Abstract][Full Text] [Related]
14. Foxc2 enhances proliferation and inhibits apoptosis through activating Akt/mTORC1 signaling pathway in mouse preadipocytes.
Gan L; Liu Z; Jin W; Zhou Z; Sun C
J Lipid Res; 2015 Aug; 56(8):1471-80. PubMed ID: 26113535
[TBL] [Abstract][Full Text] [Related]
15. ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells.
Fuchs BC; Finger RE; Onan MC; Bode BP
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C55-63. PubMed ID: 17329400
[TBL] [Abstract][Full Text] [Related]
16. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.
Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N
Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
[TBL] [Abstract][Full Text] [Related]
18. [Down-regulation of mTOR activity and survivin expression during tamoxifen-induced apoptosis in hepatoblastoma cells].
Guo RH; Wang TS; Chen XF; Huang ZH; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2010 Dec; 32(12):903-6. PubMed ID: 21223797
[TBL] [Abstract][Full Text] [Related]
19. AMPD1 regulates mTORC1-p70 S6 kinase axis in the control of insulin sensitivity in skeletal muscle.
Tandelilin AA; Hirase T; Hudoyo AW; Cheng J; Toyama K; Morisaki H; Morisaki T
BMC Endocr Disord; 2015 Mar; 15():11. PubMed ID: 25887856
[TBL] [Abstract][Full Text] [Related]
20. Thimerosal-induced apoptosis in mouse C2C12 myoblast cells occurs through suppression of the PI3K/Akt/survivin pathway.
Li WX; Chen SF; Chen LP; Yang GY; Li JT; Liu HZ; Zhu W
PLoS One; 2012; 7(11):e49064. PubMed ID: 23145070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
